Live donor transplantation may tend to be risky for patients travelling to another country for undergoing the transplant, according to a study.
The study found that patients who purchased kidneys from living donors abroad faced higher risk of organ rejection and less survival after the procedure. The study was presented at Kidney Week 2015, the annual conference of the American Society of Nephrologists.
The study compared the health outcomes of 270 commercial transplant patients with 123 recipients of living related donor transplants who had follow-up care for a transplant at a medical center in Bahrain.
Survival rates for each of the patients produced similar results, with commercial recipients surviving a year 96 percent of the time and 10 years 70 percent of the time. That compares with 98 percent of related donor recipients surviving a year and 78 percent living for another decade.
Transplant patients traveling to buy an organ were more likely to develop hepatitis B, hepatitis C and cytomegalovirus in addition to higher rates of organ rejection or other surgical complication. The most popular countries patients traveled for surgery were the Philippines, India and Pakistan.